Patient‐reported outcomes and inflammatory biomarkers in patients with locally advanced/metastatic urothelial carcinoma treated with durvalumab in phase 1/2 dose‐escalation study 1108
Journal article published in 2019 by
Peter H. O'Donnell 
,
Hendrick Tobias Arkenau,
Srikala S. Sridhar,
Michael Ong ,
Alexandra Drakaki,
Alexander I. Spira,
Jingsong Zhang,
Michael S. Gordon,
Arnold N. Degboe,
Ashok K. Gupta,
Pralay Mukhopadhyay,
Wenmei Huang,
Shaad E. Abdullah,
Natasha Angra,
Lorin K. Roskos
and other authors.
,
Hendrick Tobias Arkenau,
Srikala S. Sridhar,
Michael Ong ,
Alexandra Drakaki,
Alexander I. Spira,
Jingsong Zhang,
Michael S. Gordon,
Arnold N. Degboe,
Ashok K. Gupta,
Pralay Mukhopadhyay,
Wenmei Huang,
Shaad E. Abdullah,
Natasha Angra,
Lorin K. Roskos
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 